Document is current
Any future updates will be listed below
-
Authors
Lecomte-Thenot, Quentin
Perotin, Jeanne-Marie
Héry-Arnaud, Geneviève
Vélo-Suarez, Lourdes
Brisebarre, Audrey
Clarenne, Alice
Gouriou, Stéphanie
Dury, Sandra
Deslée, Gaëtan
Muggeo, Anaëlle
Guillard, Thomas
,
Abely, Michel
Ancel, Julien
Birembaut, Philippe
Brisebarre, Audrey
de Champs, Christophe
Delépine, Gonzague
Dormoy, Valérian
Dury, Sandra
Launois, Claire
Le Naour, Richard
Lebargy, François
Mauran, Pierre
Mérol, Jean-Claude
Mulette, Pauline
Perotin, Jeanne-Marie
Polette, Myriam
-
Funding
Funding for this research was provided by:
University Hospital of Reims
University of Reims Champagne-Ardenne
- License Information
-
More Information
Article History
Received: 11 March 2025
Accepted: 5 August 2025
First Online: 25 September 2025
Declarations
:
: J.M. Perotin reports lecture honoraria from AstraZeneca, and support for attending meetings from AstraZeneca and Chiesi, outside the submitted work. G. Deslée reports lecture honoraria from Chiesi, AstraZeneca and GlaxoSmithKline; outside the submitted work. S. Dury reports fees from Boehringer-Ingelheim and Sanofi-Adventis, outside the submitted work. Rest of the authors have no conflict of interest.
: Not applicable.
: This research was conducted in accordance with the Declaration of Helsinki, followed the rules applicable to medical research in France, and received the authorization needed. The study was approved by the regional ethics committee (Comité de Protection des Personnes—Dijon EST I, no. 2016-A00242-49). Informed consent was obtained from all the patients.
